Gad Thomas (CIK 1753224) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-18). Recent activity: Sell YMAB (245,486 shares), Sell YMAB (60,235 shares), Sell YMAB (67,681 shares), Sell YMAB (60,000 shares), Buy YMAB (103,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Sell | 245,486 | $2.1M |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Sell | 60,235 | $0 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Sell | 67,681 | $582,057 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Sell | 60,000 | $516,000 |
| 2025-06-05 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Buy | 103,000 | $206,000 |
| 2025-03-11 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Sell | 10,810 | $56,536 |
| 2025-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER | Buy | 32,000 | $0 |
Source: SEC Form 4 filings · as of 2025-09-18